ACTIVE

EXTRA-PHARMA

Export PDF

Financial year 2025 · closed on 31/03/2025

Net result

97,8 k €

-76.3% YoY

Gross margin

765,1 k €

-14.7% YoY

Equity

559,1 k €

+17.2% YoY

Workforce

8,7 ETP

-5.4% YoY

What does EXTRA-PHARMA do?

EXTRA-PHARMA is a Private limited company incorporated in 1999. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Kapellen. It employs on average 8,7 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0467.149.426

Incorporation

26/10/1999

Legal form

Private limited company

Registered office

Antwerpsesteenweg 188
2950 Kapellen · FlandreSee on map

Contributed capital

18 600,00 €

Latest accounts

31/03/2025

Average workforce

8,7 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Gross margin	765,1 k €	-14.7%	896,5 k €	+14.2%	785,3 k €	-1.4%	796,5 k €	+23.4%	645,3 k €	-4.6%	676,2 k €	+9.8%	615,7 k €	-6.3%	656,8 k €	-8.3%	716,5 k €	+4.0%	689 k €	-0.1%	690 k €	-3.5%	715 k €	+2.9%	694,9 k €	-0.6%	698,9 k €	+14.4%	610,7 k €	+2.0%	598,6 k €	+4.2%	574,5 k €	+5.6%	543,8 k €	+14.3%	475,7 k €
EBITDA	237,1 k €	-32.7%	352,2 k €	+20.7%	291,7 k €	-28.0%	405,3 k €	+42.5%	284,3 k €	-7.5%	307,2 k €	+19.8%	256,5 k €	-21.0%	324,6 k €	-16.9%	390,7 k €	+2.5%	381,1 k €	-0.6%	383,3 k €	+6.6%	359,5 k €	-4.6%	376,8 k €	+6.9%	352,3 k €	+24.6%	282,7 k €	+4.7%	270 k €	-10.9%	303,1 k €	-7.4%	327,5 k €	+23.0%	266,2 k €
Operating result	132,5 k €	-46.8%	249,3 k €	+18.1%	211,1 k €	-34.4%	321,8 k €	+50.2%	214,2 k €	-25.4%	287,2 k €	+20.6%	238,2 k €	-22.5%	307,3 k €	-15.4%	363,2 k €	+5.4%	344,5 k €	+4.2%	330,7 k €	+5.6%	313,1 k €	-4.9%	329,2 k €	+6.9%	307,8 k €	+34.3%	229,2 k €	+22.5%	187,1 k €	-7.8%	202,8 k €	-10.8%	227,4 k €	+37.5%	165,4 k €
Net result	97,8 k €	-76.3%	413,1 k €	+129%	180,4 k €	-28.6%	252,8 k €	+122%	113,7 k €	-48.8%	221,9 k €	+28.1%	173,2 k €	-20.3%	217,4 k €	-11.9%	246,6 k €	+3.0%	239,5 k €	+4.7%	228,6 k €	+3.4%	221,2 k €	-7.8%	239,8 k €	+21.7%	197,1 k €	+29.3%	152,5 k €	+37.7%	110,8 k €	-16.5%	132,7 k €	-28.3%	185,2 k €	+90.3%	97,3 k €
Balance sheet
Equity	559,1 k €	+17.2%	477,2 k €	-85.7%	3,3 M €	+4.9%	3,2 M €	+8.0%	2,9 M €	+3.4%	2,9 M €	+7.7%	2,6 M €	+7.0%	2,5 M €	+9.6%	2,3 M €	+12.3%	2 M €	+13.5%	1,8 M €	+14.8%	1,5 M €	+16.7%	1,3 M €	+22.2%	1,1 M €	+22.3%	884,1 k €	+20.8%	731,6 k €	+17.8%	620,8 k €	+27.2%	488,1 k €	+21.1%	403 k €
Total assets	3,1 M €	-10.7%	3,4 M €	-45.0%	6,2 M €	+24.0%	5 M €	+15.0%	4,4 M €	+21.7%	3,6 M €	+4.0%	3,5 M €	+6.9%	3,2 M €	+5.7%	3,1 M €	+11.4%	2,7 M €	-0.6%	2,8 M €	+1.5%	2,7 M €	+3.9%	2,6 M €	+6.0%	2,5 M €	+9.3%	2,3 M €	+1.7%	2,2 M €	+2.9%	2,2 M €	-2.1%	2,2 M €	+9.4%	2 M €
Cash	159,8 k €	-64.2%	446 k €	+160%	171,8 k €	-43.6%	304,8 k €	-12.7%	349,1 k €	+34.2%	260,1 k €	-51.5%	536,8 k €	+52.4%	352,2 k €	+34.0%	262,8 k €	-4.8%	276 k €	+9.5%	252,1 k €	-16.8%	303,1 k €	+25.3%	241,9 k €	-44.3%	434 k €	-25.9%	585,3 k €	+26.3%	463,3 k €	-12.2%	528 k €	-16.9%	635,3 k €	-10.5%	710 k €
Debts	2,5 M €	-15.2%	2,9 M €	+1.7%	2,9 M €	+56.7%	1,8 M €	+29.7%	1,4 M €	+92.3%	741,9 k €	-8.3%	809,1 k €	+6.3%	761 k €	-5.2%	802,9 k €	+9.1%	735,8 k €	-25.8%	991,4 k €	-15.9%	1,2 M €	-9.2%	1,3 M €	-6.6%	1,4 M €	+1.0%	1,4 M €	-7.7%	1,5 M €	-3.2%	1,5 M €	-10.4%	1,7 M €	+6.5%	1,6 M €
Other
Workforce	8,7 ETP	-5.4%	9,2 ETP	+4.5%	8,8 ETP	+11.4%	7,9 ETP	+16.2%	6,8 ETP	-2.9%	7,0 ETP	+2.9%	6,8 ETP	-2.9%	7,0 ETP	+1.4%	6,9 ETP	0.0%	6,9 ETP	-1.4%	7,0 ETP	+4.5%	6,7 ETP	-6.9%	7,2 ETP	-2.7%	7,4 ETP	+17.5%	6,3 ETP	-25.9%	8,5 ETP	+26.9%	6,7 ETP	+28.8%	5,2 ETP	0.0%	5,2 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/03/2025 · 2 active · 7 ended

Active mandates

Cavely

Director · since 02 avril 2024 · 1007.012.626

Represented by Carlijn Van den Eede

Active

VERLUCO

Director · until 02 avril 2024 · 0862.542.212

Represented by Luc Roger J Van den Eede

Active

Ended mandates

Luc Van Den Eede

Manager

Ended

VERLUCO

Manager · 0862.542.212

Represented by Luc Van Den Eede

Ended

VERLUCO

Manager · 0862.542.212

Represented by Luc Van Den Eede

Ended

VERLUCO

Director · until 02 avril 2024 · 0862.542.212

Represented by Luc Roger J Van den Eede

Ended

At this address

Other companies at this address

Company	CBE no.
Cavely● Active	1007.012.626

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/04/2024	01/04/2023	01/04/2022	01/04/2021	01/04/2020	01/04/2019
Closing of the financial year	31/03/2025	31/03/2024	31/03/2023	31/03/2022	31/03/2021	31/03/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/09/2025	29/10/2024	31/10/2023	28/10/2022	15/11/2021	17/11/2020
General meeting	17/09/2025	28/08/2024	23/08/2023	24/08/2022	15/09/2021	16/09/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/03/2025	17/09/2025	29/09/2025	Dutch	PDF
Abridged model	31/03/2024	28/08/2024	29/10/2024	Dutch	PDF
Abridged model	31/03/2023	23/08/2023	31/10/2023	Dutch	PDF
Abridged model	31/03/2022	24/08/2022	28/10/2022	Dutch	PDF
Abridged model	31/03/2021	15/09/2021	15/11/2021	Dutch	PDF
Abridged model	31/03/2020	16/09/2020	17/11/2020	Dutch	PDF
Abridged model	31/03/2019	28/08/2019	24/10/2019	Dutch	PDF
Abridged model	31/03/2018	22/08/2018	27/09/2018	Dutch	PDF
Abridged model	31/03/2017	23/08/2017	14/09/2017	Dutch	PDF
Abridged model	31/03/2016	24/08/2016	06/09/2016	Dutch	PDF
Abridged model	31/03/2015	26/08/2015	22/09/2015	Dutch	PDF
Abridged model	31/03/2014	27/08/2014	20/10/2014	Dutch	PDF
Abridged model	31/03/2013	28/08/2013	30/09/2013	Dutch	PDF
Abridged model	31/03/2012	22/08/2012	19/10/2012	Dutch	PDF
Abridged model	31/03/2011	14/09/2011	03/10/2011	Dutch	PDF
Abridged model	31/03/2010	15/09/2010	21/10/2010	Dutch	PDF
Abridged model	31/03/2009	16/09/2009	28/09/2009	Dutch	PDF
Abridged model	31/03/2008	17/09/2008	28/10/2008	Dutch	PDF
Abridged model	31/03/2007	12/09/2007	22/10/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/03/2025 · 2 active · 7 ended

Active mandates

Cavely

Director · since 02 avril 2024 · 1007.012.626

Represented by Carlijn Van den Eede

Active

VERLUCO

Director · until 02 avril 2024 · 0862.542.212

Represented by Luc Roger J Van den Eede

Active

Ended mandates

Luc Van Den Eede

Manager

Ended

VERLUCO

Manager · 0862.542.212

Represented by Luc Van Den Eede

Ended

VERLUCO

Manager · 0862.542.212

Represented by Luc Van Den Eede

Ended

VERLUCO

Director · until 02 avril 2024 · 0862.542.212

Represented by Luc Roger J Van den Eede

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates27/05/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates20/10/2020
DOEL - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM
PDF
Capital / shares01/12/2005
ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates12/04/2005
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202597,8 k €↓
2024
Annual accounts 2024413,1 k €↑
2023
Annual accounts 2023180,4 k €↓
2022
Annual accounts 2022252,8 k €↑
2021
Annual accounts 2021113,7 k €↓
2020
Annual accounts 2020221,9 k €↑
2019
Annual accounts 2019173,2 k €↓
2018
Annual accounts 2018217,4 k €↓
2017
Annual accounts 2017246,6 k €↑
2016
Annual accounts 2016239,5 k €↑
2015
Annual accounts 2015228,6 k €↑
2014
Annual accounts 2014221,2 k €↓
2013
Annual accounts 2013239,8 k €↑
2012
Annual accounts 2012197,1 k €↑
2011
Annual accounts 2011152,5 k €↑
2010
Annual accounts 2010110,8 k €↓
2009
Annual accounts 2009132,7 k €↓
2008
Annual accounts 2008185,2 k €↑
2007
Annual accounts 200797,3 k €
26/10/1999
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

EXTRA-PHARMA

Overview

What does EXTRA-PHARMA do?

Trend over 19 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline